Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

Chronic Lymphocytic Leukemia: Where Are We Now and Where Are We Going? Andrea Sitlinger, MD Assistant Professor of Medicine Hematologic Malignancies and Cellular Therapy Duke Cancer Institute Disclosure of Conflicts of Interest Andrea Sitlinger, MD has the following financial relationships to disclose: • Consultant – BeiGene, TG Therapeutics • Speaker – Innate Pharma …
Optimizing value in molecular testing North Carolina Oncology Association Annual Conference Jason D. Merker, MD, PhD Associate Professor, Pathology and Laboratory Medicine & Genetics Director, Molecular Oncology jason_merker@med.unc.edu September 10, 2022 Disclosure of Conflicts of Interest Jason D. Merker, MD, PhD has the following financial relationships to disclose: …
Updates in Thoracic Oncology Tom Stinchcombe, MD Professor of Medicine Duke Cancer Institute Disclosure of Conflicts of Interest Activity Company Advisory board or data monitoring committee EMD Serono, Novartis, Janssen Oncology, Turning Point Therapeutics, Sanofi/Aventis, GlaxoSmithKline, Genentech/Roche, Daiichi Sankyo/Astra Zeneca, Takeda Research Funding …
Metastatic Colon and Rectal Cancer Updates, ASCO 2022 Colorectal and Anal Cancer Justin Chau, MD Hematology, Oncology, and Blood & Marrow Transplantation University of Iowa Hospitals and Clinics Disclosures I have no disclosures to report. Permission was obtained from ASCO to use the following slides from its 2022 Annual Meeting in this presentation. What …
CHANGING MEDICINE. CHANGING LIVES.® Colorectal & Anal Cancer Saima Sharif, MD MS September 9, 2022 Celebrating 150 years of advancing medical research, education, and patient care to help people live longer, healthier lives Disclosure of Conflict of Interest Insert->Header and Footer->Type Customizable Name Saima Sharif, MD, MS has the following relationship to …
Upper GI Hepatobiliary/Pancreatic Cancers Naomi Fei, MD MS University of Iowa Holden Cancer Center 9/9/22 Disclosure of Conflicts of Interest Naomi Fei, MD MS, has no financial relationships to disclose. Outline • Sequential Chemotherapy: SEQUENCE • Targeting mutant KRAS in PDAC: KRYSTAL-1 • KRAS WT PDAC: NOTABLE • Available Trials at UIHC …
An in-person conference event, featuring educational and networking opportunities for the multidisciplinary cancer care team on how to implement innovation in care delivery. West Palm Beach, Fla. — Oncology professionals will convene October 12-14, 2022, in West Palm Beach, Fla., to learn from and network with their colleagues through an engaging and interactive three-day agenda at the ACCC 39th National …
ASCO 2022 Updates – Spotlight on Breast Cancer Sneha Phadke, DO MPH Clinical Associate Professor Breast Medical Oncologist University of Iowa Holden Comprehensive Cancer Center Disclosures • Research support from Astra-Zeneca, Pfizer, Roche, Laekna • Many of the slides are courtesy of clinicaloptions.com or were adapted from them, tailored to the objectives of this …
Lung Cancer Maggie Byrne, MD, MS Clinical Assistant Professor Holden Comprehensive Cancer Center, University of Iowa Maggie Byrne, MD, MS has no relevant financial relationships to disclose. Disclosure of Conflicts of Interest Metastatic NSCLC without targetable genomic alterations 1st line Abstract 9000, Pooled analysis of 12 randomized studies comparing IO vs …
CHANGING MEDICINE. CHANGING LIVES.® Multiple Myeloma Updates from ASCO 2022 Christopher Strouse MD September 9th, 2022 Holden Comprehensive Cancer Center Disclosures • Advisory board –Glaxo Smith Kline • We will discuss off label / investigational uses Holden Comprehensive Cancer Center Acknowledgements • Thank you to the abstract presenters for use of their …
Lymphomas Sabarish Ayyappan MD Clinical Assistant Professor of Medicine University of Iowa Hospitals and Clinics Disclosure of Conflicts of interest Sabarish Ayyappan MD has the following financial relationships to disclose: Research Support - Genmab, Regeneron , Astrazeneca, Innate Pharmaceuticals, Beigene, Pfizer, Xencor, Roche/Genentech Consultant- Fate therapeutics, …
UPDATES IN SOFT TISSUE SARCOMA John Rieth, MD Disclosure of Conflicts of Interest ◦ John Rieth, MD has no relevant financial relationships to disclose. Soft-Tissue Sarcoma ◦ Very diverse family of tumors derived from primitive mesenchymal stem cells ◦ Chemotherapy resistant ◦ Radiation resistant (except for myxoid liposarcoma) ◦ Frequently immunologically …
Social Media in Hematology/Oncology Udhayvir Singh Grewal, MD Fellow, Division of Hematology, Oncology, Blood and Marrow Transplantation University of Iowa Hospitals and Clinics, Iowa City, IA Disclosures: None Social Media in Hematology/Oncology 09/07/2022 Division of Hematology, Oncology, Blood and Marrow Transplantation Why should we care about social …
Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients With Renal Cell Carcinoma Dean Elhag, MD University of Iowa Hospital: Division of Hematology, Oncology, and Blood & Marrow Transplantation Disclosure of Conflicts of Interest • Dean Elhag, MD has no relevant financial relationships to disclose. Learning Objective • Use new knowledge …
Prajwal Dhakal, MBBS Clinical Assistant Professor Division of Hematology, Oncology, Blood & Marrow Transplantation University of Iowa Disclosure of Conflicts of Interest Prajwal Dhakal, MBBS has no relevant financial relationships to disclose. Acute lymphoblastic leukemia Characteristic N (%) / median [range] Category ND ALL N = 35 R/R ALL N = 14 …
Fred Hutchinson Cancer Center invites you to the 13TH ANNUAL COMPREHENSIVE HEMATOLOGY & ONCOLOGY REVIEW COURSE This program is designed for those interested in a comprehensive update on solid tumors and hematologic disorders, including those certifying or re‑certifying for their boards. Register online: https://cvent.me/eP8ggb or here F In-Person Program September 28–October 2, 2022 Motif …
EXECUTIVE OFFICE: 1801 Research Boulevard • Suite 400 • Rockville, MD 20850-3184 • Phone: 301.984.9496 • Fax: 301.770.1949 www.accc-cancer.org OFFICERS President David R. Penberthy, MD, MBA Bon Secours, Southside Regional Medical Center Petersburg, VA President-Elect Olalekan Ajayi, PharmD, MBA Highlands Oncology Group, P.A. …
On August 18, ACCC President David R. Penberthy, MD, hosted his second Tech Talk, as 40 ACCC members came together to brainstorm technology solutions to mitigate oncology workforce shortages. Learn about the day’s discussion and the variety of artificial intelligence (AI)- and business intelligence (BI)-enabled platforms that are available to support your workforce.
PowerPoint Presentation Authors: Joseph Kim1, Elana Plotkin2, Leigh Boehmer2, Timothy Craig Allen3, Pablo Gutman4, Michelle Shiller5, Sandra Brown6, Vivian Pan7 1Xaf Solutions, Newtown, PA; 2Association of Community Cancer Centers, Rockville, MD; 3University of Mississippi Medical Center, Jackson, MS; 4Holy Cross Health, Silver Spring, MD; 5Baylor Scott & White Health, Dallas, TX; 6Providence …
Presented at The American Society for Clinical Pathology (ASCP) 2022 Annual Meeting, September 7-9, 2022.